Cross-kingdom health: evolution of innate immune receptors and their targets
Project Number1DP2AT011967-01
Former Number1DP2OD030699-01
Contact PI/Project LeaderKRASILEVA, KSENIA V
Awardee OrganizationUNIVERSITY OF CALIFORNIA BERKELEY
Description
Abstract Text
PROJECT SUMMARY
Innate immune receptors from the NLR protein family control basic organism-organism interactions across
kingdoms, including incompatibility within a species. Current availability of genomic biodiversity allows
us to examine patterns of innate immune receptor evolution. I propose that adaptive immunity has evolved
by adopting subsets of proteins domains already present in innate immunity as well as their diversification
mechanisms to act somatically in specialized cells. Testing this hypothesis through comparative genomics
will be paradigm-shifting to our understanding of immune system evolution. To do this, we will examine
evolution of protein domains involved in innate immunity across all available eukaryotic genomes,
determine sources of genomic diversity and how they change with the re-current evolution of adaptive
immunity across independent lineages. To test that there are targeted diversity generation mechanisms
acting on NLRs at the population level, we will examine patterns of NLR evolution on multiple scales,
including cross-kingdom analyses. We will test diversification mechanisms acting on them within species
lacking adaptive immunity, including model plants and fungi. In parallel, we will experimentally test
involvement of NLRs in fungal immunity, which has been proposed but yet to be experimentally validated.
Finally, we will conduct experimental evolution on both NLRs and their ligands to collect data for modeling
how new binding specificities arise on the population scale. Altogether, this project will fill in important
gaps in understanding the evolution of innate immune systems, including our own.
Public Health Relevance Statement
PROJECT NARRATIVE
Innate immunity is encoded in germline, yet on population level it is sufficient to recognize any pathogen
even in absence of adaptive immunity. Exactly how new recognition specificities arise in innate immune
receptors remain unknown. This project will address this fundamental gap and develop experimental and
computational approaches to understand the evolution of innate immunity.
National Center for Complementary and Integrative Health
CFDA Code
213
DUNS Number
124726725
UEI
GS3YEVSS12N6
Project Start Date
15-September-2021
Project End Date
31-August-2024
Budget Start Date
15-September-2021
Budget End Date
31-August-2024
Project Funding Information for 2021
Total Funding
$1,306,037
Direct Costs
$900,000
Indirect Costs
$406,037
Year
Funding IC
FY Total Cost by IC
2021
NIH Office of the Director
$1,306,037
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1DP2AT011967-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1DP2AT011967-01
Patents
No Patents information available for 1DP2AT011967-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1DP2AT011967-01
Clinical Studies
No Clinical Studies information available for 1DP2AT011967-01
News and More
Related News Releases
No news release information available for 1DP2AT011967-01
History
No Historical information available for 1DP2AT011967-01
Similar Projects
No Similar Projects information available for 1DP2AT011967-01